Journal of psychosomatic research · 2025
Effectiveness and influence of mindfulness-based intervention on migraine patients: A systematic review and meta-analysis.
СтатьяМетаанализСистематический обзорПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liao Yu-Chi, Chen Wen-Shuan, Restya Winda Putri Diah, Liao Yu-Chun, Lin Yi-Chun, Lin Ro-Ting
Аннотация
PURPOSE: Migraines are among the top causes of global disability and are often managed with pharmacological treatments, which may produce adverse effects. Mindfulness-based interventions (MBIs) have emerged as promising non-pharmacological approaches, yet existing studies report mixed findings. This meta-analysis aimed to clarify the effectiveness of MBIs in improving pain, psychological, and functional outcomes among adults with migraine.
METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) involving adults (≥18 years) with a clinical diagnosis of migraine. Four databases-Medline, CINAHL, Scopus, and ProQuest Central-were searched from 1982 to July 2025. Risk of bias was assessed using the Cochrane RoB 2.0 tool. Meta-analyses were performed using Comprehensive Meta-Analysis Software Version 4 and R.
RESULTS: Fourteen RCTs with 1027 participants were included. MBIs were associated with significant reductions in pain intensity (standardized mean difference: 0.23 [95 % CI: 0.11-0.35]) and pain frequency (0.33 [0.11-0.54]), as well as improvements in quality of life (0.24 [0.08-0.40]). Psychological outcomes improved significantly, including anxiety (0.37 [0.14-0.61]), depression (0.26 [0.06-0.45]), and pain catastrophizing (0.57 [0.35-0.80]). No significant effects were found for activity-related disability (0.18 [-0.01-0.38]) or use of analgesic medications (0.07 [-0.06-0.20]) and triptans (0.04 [-0.13-0.21]).
CONCLUSIONS: MBIs may serve as effective complements to pharmacological treatments for migraine. They significantly reduce pain intensity, attack frequency, and psychological symptoms, while modestly improving quality of life. These findings support integrating mindfulness practices into routine migraine care to promote psychological well-being and reduce symptom burden.
METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) involving adults (≥18 years) with a clinical diagnosis of migraine. Four databases-Medline, CINAHL, Scopus, and ProQuest Central-were searched from 1982 to July 2025. Risk of bias was assessed using the Cochrane RoB 2.0 tool. Meta-analyses were performed using Comprehensive Meta-Analysis Software Version 4 and R.
RESULTS: Fourteen RCTs with 1027 participants were included. MBIs were associated with significant reductions in pain intensity (standardized mean difference: 0.23 [95 % CI: 0.11-0.35]) and pain frequency (0.33 [0.11-0.54]), as well as improvements in quality of life (0.24 [0.08-0.40]). Psychological outcomes improved significantly, including anxiety (0.37 [0.14-0.61]), depression (0.26 [0.06-0.45]), and pain catastrophizing (0.57 [0.35-0.80]). No significant effects were found for activity-related disability (0.18 [-0.01-0.38]) or use of analgesic medications (0.07 [-0.06-0.20]) and triptans (0.04 [-0.13-0.21]).
CONCLUSIONS: MBIs may serve as effective complements to pharmacological treatments for migraine. They significantly reduce pain intensity, attack frequency, and psychological symptoms, while modestly improving quality of life. These findings support integrating mindfulness practices into routine migraine care to promote psychological well-being and reduce symptom burden.